Fundraising Fox

Vistara

5 known investors

VistaraBio provides research tools and services for drug discovery, including modified protein assays, post-translationally modified protein catalogs, and cell screening platforms using bioactive peptides. The company serves pharmaceutical and biotech researchers developing small molecule and protein degrader therapeutics.

BiotechDeep Tech

Founders & leadership

GN
Girish Nallur, PhD CLPinFounder

Investors · 5

Connecticut InnovationsNew Haven · $500K – $2M
Armitage Associatesreported$10M – $30M
Integrity Growth PartnersreportedLos Angeles
Plymouth GrowthreportedAnn Arbor · $5M – $25M
Vistara GrowthreportedVancouver

In the news

Vistara Growth Announces Final Close of Fund V at US$321Mvistaragrowth.com · Nov 2025Vistara Growth closes $321-million USD fund after “friend-raising to the max” | BetaKitbetakit.com · Nov 2025Vistara Growth Tracking Toward September 30 Final Close With Over US$265 Million Raised to Datebusinesswire.com · Sep 2025Algo Raises $20 Million Funding From Vistara Growth To Accelerate Global Expansion and AI Solution Delivery | Vistara Growthvistaragrowth.com · Jan 2024Vistara raises initial $150m-plus for fifth software growth fundventurecapitaljournal.com · Dec 2023

Frequently asked questions

What does Vistara do?
VistaraBio provides research tools and services for drug discovery, including modified protein assays, post-translationally modified protein catalogs, and cell screening platforms using bioactive peptides. The company serves pharmaceutical and biotech researchers developing small molecule and protein degrader therapeutics.
Who founded Vistara?
Vistara was founded by Girish Nallur, PhD CLP.
Who are Vistara's investors?
Vistara's investors include Connecticut Innovations, Armitage Associates, Integrity Growth Partners, Plymouth Growth, Vistara Growth.